Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up production
This story matters for Finance & Markets readers tracking largecap. Reported by cnbc.com. Read the full original at the source link below.
Originally reported by cnbc.com. LargecapNews curates and briefs the finance & markets stories that matter. Our editorial policy →